{"database": "lobbying", "table": "lobbying_activities", "rows": [[1555830, "a3cc922f-79ea-409d-a421-8ed011623d70", "Q2", "FTI GOVERNMENT AFFAIRS", 401054971, "AMERICAS HEALTH INSURANCE PLANS (AHIP)", 2014, "second_quarter", "PHA", "H.R. 460, Patients' Access to Treatments Act (McKinley) - cost sharing in a specialty drug tier. H.R. 1367, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act (Lynch) - FEHBP prescription drugs. H.R. 3204, Drug Quality and Security Act (Upton) - drug safety issues. S. 214, Preserve Access to Affordable Generics Act (Klobuchar) - access to generic drugs.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2014-07-17T13:09:25.093000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1555830"], "units": {}, "query_ms": 3.8059549988247454, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}